| 2007 | | A Case of a Rectal Teratoma | 오승엽, 이광재,김영배, 서광욱 |
| 2011 | | Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancer. | 서광욱, 김영배 |
| 2017 | | Accuracy of Preoperative Local Staging of Primary Colorectal Cancer by Using Computed Tomography: Reappraisal Based on Data Collected at a Highly Organized Cancer Center | 정진옥, 오승엽,이제희, 김영배,서광욱 |
| 2015 | | ALDH1 is a prognostic factor for patients treated with neoadjuvant chemoradiotherapy and radical resection for stage III rectal cancer. | 오승엽, 임현이,이다근, 서광욱,김영배 |
| 2000 | | Antigen-specific immunotherapy for human papillomavirus 16 E7-expressing tumors grown in the liver. | 서광욱 |
| 2018 | | Changes in anorectal physiology following injection sclerotherapy using aluminum potassium sulfate and tannic acid versus transanal repair in patients with symptomatic rectocele: a retrospective cohort study | 김주형, 서광욱 |
| 2014 | | Clinical application of sentinel lymph node mapping in colon cancer: in vivo vs. ex vivo techniques. | 오승엽, 김도윤,김영배, 서광욱 |
| 2009 | | Comparison of Effects of Preoperative Stenting for Obstructing Colorectal Cancers according to the Location of the Obstructing Lesion | 오승엽, 서광욱,이명희, 전수진,김진홍, 이광재 |
| 2013 | | Comparison of oncological outcomes between neoadjuvant and adjuvant chemotherapy combined with surgery for resectable synchronous colorectal liver metastases. | 오승엽, 김도윤,김영배, 서광욱 |
| 2007 | | Complications, Mortality and Functional Outcome following a Total Colectomy and Ileo-rectal Anastomosis | 오승엽, 서광욱 |
| 2011 | | Computed tomography classification for parastomal hernia. | 오승엽, 이제희,서광욱 |
| 2009 | | Contiguous invasion per se does not affect prognosis in colon cancer. | 오승엽, 김영배,백옥주, 서광욱 |
| 2001 | | Controlled local delivery of interleukin-2 by biodegradable polymers protects animals from experimental brain tumors and liver tumors. | 서광욱 |
| 2008 | | Does a Successful Total Mesorectal Excision Require a Learning Curve? | 오승엽, 서광욱 |
| 2011 | | Does total mesorectal excision require a learning curve? Analysis from the database of a single surgeon's experience. | 오승엽, 김영배,서광욱 |
| 2017 | | Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study | 서광욱 |
| 1999 | | Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs. | 서광욱 |
| 2019 | | In-Depth Risk Factor Analysis Shows Laparoscopic Procedure Does Not Show Superiority in the Prevention of Postoperative Ileus after Curative Surgery for Colorectal Cancer | 서광욱 |
| 2002 | | Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision? | 서광욱, 전미선,임호영 |
| 2019 | | Long-term follow-up of Starion™ versus Harmonic Scalpel™ hemorrhoidectomy for grade III and IV hemorrhoids | 김주형, 서광욱 |
| 2016 | | MicroRNA Expression Signatures Associated With BRAF-Mutated Versus KRAS-Mutated Colorectal Cancers | 최용원, 이현우,김영배, 서광욱,이다근 |
| 2010 | | Microsatellite Instability-low Colorectal Carcinomas: Are They Comparable with Microsatellite Stable Cancer? | 오승엽, 김영배,서광욱 |
| 2017 | | Oncologic Outcome of ypT1-2N0 Rectal Cancer After Neoadjuvant Chemoradiotherapy Compared With pT1-2N0 Rectal Cancer | 오승엽, 김영배,서광욱 |
| 2013 | | Oncologic outcomes after adjuvant chemotherapy using FOLFOX in MSI-H sporadic stage III colon cancer. | 오승엽, 김도윤,김영배, 서광욱 |
| 2015 | | Oncologic outcomes following metastasectomy in colorectal cancer patients developing distant metastases after initial treatment. | 오승엽, 서광욱 |
| 2007 | | Oncological Safety of a Metallic Stent for a Left-sided Obstructive Colorectal Carcinoma | 오승엽, 이광재,김진홍, 서광욱 |
| 2013 | | Preoperative colonoscopy for detection of synchronous neoplasms after insertion of self-expandable metal stents in occlusive colorectal cancer: comparison of covered and uncovered stents. | 임선교, 이광재,서광욱, 오승엽,김순선, 유준환 |
| 2014 | | Preoperative Localization of Early Colorectal Cancer or a Malignant Polyp by Using the Patient’s Own Blood | 김도윤, 오승엽,이광재, 서광욱 |
| 2015 | | Preoperative neutrophil to lymphocyte ratio predicts survival in patients with T1-2N0 colorectal cancer. | 서광욱, 오승엽 |
| 2016 | | Preoperative thrombocytosis predicts prognosis in stage II colorectal cancer patients | 서광욱, 오승엽 |
| 2014 | | Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer. | 김도윤, 오승엽,김영배, 이제희,서광욱 |
| 2012 | | Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer | 오승엽, 김영배,서광욱 |
| 2017 | | Prognostic Significance of Lymphocyte Counts in Colon Cancer Patients Treated with FOLFOX Chemotherapy | 노오규, 오승엽,김영배, 서광욱 |
| 2017 | | Prognostic significance of systemic inflammatory response in stage II colorectal cancer | 오승엽, 김영배,서광욱 |
| 2013 | | Risk factors for parastomal hernia: based on radiological definition. | 오승엽, 이제희,김도윤, 서광욱 |
| 2012 | | Routine barium enema prior to closure of defunctioning ileostomy is not necessary | 김도윤, 오승엽,서광욱 |
| 2016 | | Sustaining Blood Lymphocyte Count during Preoperative Chemoradiotherapy as a Predictive Marker for Pathologic Complete Response in Locally Advanced Rectal Cancer | 허재성, 전미선,노오규, 오영택,서광욱, 박준은,조오연 |
| 2007 | | The Efficacy of UGT1A1 Polymorphism in Chemoradiation Therapy Using Irinotecan in Patients with Locally Advanced Rectal Cancer | 오승엽, 김영배,전미선, 서광욱 |
| 2005 | | Thymidylate synthase gene polymorphism as a prognostic factor for colon cancer. | 서광욱, 김영배 |
| 2009 | | Total Number of Lymph Nodes Retrieved in Stage III Rectal Cancer Patient. | 오승엽, 백옥주,김영배, 서광욱 |
| 2009 | | Treatment of Multiple Colorectal Cancers | 백옥주, 오승엽,서광욱 |
| 2017 | | TrkC promotes colorectal cancer growth and metastasis | 서광욱 |
| 2019 | | Ultralow Anterior Resection and Coloanal Anastomosis for Low-Lying Rectal Cancer: An Appraisal Based on Bowel Function | 정진옥, 오승엽,서광욱 |
| 2006 | | Which gene is a dominant predictor of response during FOLFOX chemotherapy for the treatment of metastatic colorectal cancer, the MTHFR or XRCC1 gene? | 서광욱, 김영배 |
